Scottish company Ingenza, a leader in the application of industrial biotechnology and synthetic biology, has become a stakeholder in Amprologix, a spin-out company from the University of Plymouth. Launched in collaboration with Frontier IP – a specialist in commercialising university intellectual property and a stakeholder in the new company – Amprologix aims to develop and bring to market novel antimicrobials to tackle antibiotic resistance, a global threat to human health.
“Imagine wearing yoga pants made from recycled carbon!” said LanzaTech Ceo, Jennifer Holmgren. “We want people to have a choice of where their carbon comes from. Fresh fossil or recycled, ‘carbon smart’, products. Much like the idea of buying organic, fair trade or recycled products, we see a future where you can walk into a store and make a conscious decision to buy everything from a chair to running shoes made from recycled carbon. This future is now possible through advancements in synthetic biology which enable the production of targeted molecules.”
Scotland is set to create waves among the global biotechnology arena as its Industrial Biotechnology Innovation Centre (IBioIC) announces over £3 million of investment across six game changing synthetic biology projects including greener skincare products, more sustainable plastics and improvements to personalised medicine therapies.